CHARACTERIZING EPIGENETIC MODULATIONS AND EZHIP DOWNSTREAM TARGETS IN PFA EPENDYMOMA

被引：0
|
作者：
Wang, Shanzheng [1 ,2 ,3 ]
Jenseit, Anne [1 ,2 ,3 ]
Huebner, Jens-Martin [1 ,2 ,3 ]
Mauermann, Monika [1 ,2 ,3 ]
Okonechnikov, Konstantin [1 ,2 ,3 ]
Pfister, Stefan M. [1 ,2 ,3 ,4 ]
Kool, Marcel [1 ,2 ,3 ,5 ,6 ]
机构：
[1] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Baden Wurttembe, Germany
[2] German Canc Res Ctr, Heidelberg, Baden Wurttembe, Germany
[3] German Canc Consortium DKTK, Heidelberg, Baden Wurttembe, Germany
[4] Heidelberg Univ, Fac Biosci, Heidelberg, Baden Wurttembe, Germany
[5] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[6] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.213
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EPEN-11
引用
收藏
页数：2
相关论文
共 14 条
  • [1] Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
    Pratt, Drew
    Quezado, Martha
    Abdullaev, Zied
    Hawes, Debra
    Yang, Fusheng
    Garton, Hugh J. L.
    Judkins, Alexander R.
    Mody, Rajen
    Chinnaiyan, Arul
    Aldape, Kenneth
    Koschmann, Carl
    Venneti, Sriram
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [2] Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
    Drew Pratt
    Martha Quezado
    Zied Abdullaev
    Debra Hawes
    Fusheng Yang
    Hugh J. L. Garton
    Alexander R. Judkins
    Rajen Mody
    Arul Chinnaiyan
    Kenneth Aldape
    Carl Koschmann
    Sriram Venneti
    Acta Neuropathologica Communications, 8
  • [3] Autopsy findings of previously described case of diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
    Murad Alturkustani
    Jennifer A. Cotter
    Roshan Mahabir
    Debra Hawes
    Carl Koschmann
    Sriram Venneti
    Alexander R. Judkins
    Linda J. Szymanski
    Acta Neuropathologica Communications, 9
  • [4] Autopsy findings of previously described case of diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
    Alturkustani, Murad
    Cotter, Jennifer A.
    Mahabir, Roshan
    Hawes, Debra
    Koschmann, Carl
    Venneti, Sriram
    Judkins, Alexander R.
    Szymanski, Linda J.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2021, 9 (01)
  • [5] Predicting prognosis in PFA ependymoma and group 3/4 medulloblastoma methylomes using interpretable epigenetic models
    Ng, Indy
    Fricke, Alexander
    Pai, Shraddha
    CANCER RESEARCH, 2022, 82 (12)
  • [6] PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
    Siddhant U. Jain
    Truman J. Do
    Peder J. Lund
    Andrew Q. Rashoff
    Katharine L. Diehl
    Marcin Cieslik
    Andrea Bajic
    Nikoleta Juretic
    Shriya Deshmukh
    Sriram Venneti
    Tom W. Muir
    Benjamin A. Garcia
    Nada Jabado
    Peter W. Lewis
    Nature Communications, 10
  • [7] PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
    Jain, Siddhant U.
    Do, Truman J.
    Lund, Peder J.
    Rashoff, Andrew Q.
    Diehl, Katharine L.
    Cieslik, Marcin
    Bajic, Andrea
    Juretic, Nikoleta
    Deshmukh, Shriya
    Venneti, Sriram
    Muir, Tom W.
    Garcia, Benjamin A.
    Jabado, Nada
    Lewis, Peter W.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [8] Identifying and characterizing downstream targets of T-box transcription factors
    Maxwell, Adrienne A.
    Ma, Taylur
    Moens, Cecilia
    Amacher, Sharon L.
    DEVELOPMENTAL BIOLOGY, 2010, 344 (01) : 460 - 461
  • [9] Epigenetic regulation and downstream targets of the Rhox5 homeobox gene
    Shanker, S.
    Hu, Z.
    Wilkinson, M. F.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2008, 31 (05): : 462 - 470
  • [10] Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors
    Madkour, Moustafa M.
    Ramadan, Wafaa S.
    Saleh, Ekram
    El-Awady, Raafat
    ANNALS OF MEDICINE, 2023, 55 (01)
12